ITM - Expertise Partner
ITM, a leading radiopharmaceutical biotech company, is dedicated to providing a new generation of radiomolecular precision therapeutics and diagnostics for hard-to-treat tumors. We aim to meet the needs of cancer patients, clinicians and our partners through excellence in development, production and global supply. With improved patient benefit as the driving principle for all we do, ITM advances a broad precision oncology pipeline, including two phase III studies, combining the company’s high-quality radioisotopes with a range of targeting molecules. By leveraging our nearly two decades of pioneering radiopharma expertise, central industry position and established global network, ITM strives to provide patients with more effective targeted treatment to improve clinical outcome and quality of life.
Radiopharm Theranostics - Industry Partner
Radiopharm Theranostics is a clinical stage radiotherapeutics company developing a world-class platform of innovative radiopharmaceutical products for diagnostic and therapeutic applications in areas of high unmet medical need. Radiopharm is listed on ASX (ticker: RAD) since November 2021. The company has a pipeline of four distinct and highly differentiated platform technologies spanning peptides, small molecules and monoclonal antibodies for use in cancer, in pre-clinical and clinical stages of development from some of the world’s leading universities and institutes. The pipeline has been built based on the potential to be First to Market or Best in Class.
ABX-CRO - Hosting Partner
The independent full-service CRO for cutting-edge research in neuroscience, oncology and molecular imaging. With a unique translational medicine approach, we are happy to develop your product from bench to bedside. The independent full-service CRO for cutting-edge research in neuroscience, oncology and molecular imaging. With a unique translational medicine approach, we are happy to develop your product from bench to bedside. The independent full-service CRO for cutting-edge research in neuroscience, oncology and molecular imaging. With a unique translational medicine approach, we are happy to develop your product from bench to bedside.
Oncodesign - Hosting Partner
For more than 25 years, Oncodesign has been investing in precision medicine research technologies, which are essential from the very first stages of the Drug Discovery process.
Our technology modules allow a continuum from molecule to patient, with the goal of discovering new treatments for patients with no therapeutic options.
Ionetix - Innovation Partner
Ionetix is a full-service, end-to-end radiopharmaceutical solutions provider. Utilizing a proprietary cyclotron technology platform, Ionetix develops innovative accelerator solutions to produce medical radioisotopes used for both diagnostic and therapeutic radiopharmaceuticals.
Ionetix is currently in the process of establishing the first commercial alpha isotope manufacturing and distribution facility dedicated to the production of Actinium-225 (Ac-225) and Astatine-211 (At- 211). Ionetix will provide isotope production, drug manufacturing and distribution logistics for these alpha isotopes beginning in early 2023.
Field-Lab - Innovation Partner
FIELD-LAB is a drug discovery consortium that will help you to speed up the development and market launch of new nuclear drugs for cancer treatment. Through supply of research batches of radio chemicals and radio pharmaceuticals, we meet the need of biopharma
scientists and start-up ventures for research materials. This will drive your ambitions to develop a new drug. FIELD-LAB is created for and together with partners from different backgrounds. Some of the finest Dutch and British UMC’s have committed themselves to be part of this initiative.
They believe in the beneficial results that will be brought to the Nuclear Medicine society. In addition, the partnerships that arise from FIELD-LAB form a portal to a fast-growing network, which results in an open innovation environment.
PMB-Alcen - Innovation Partner
PMB is a human-sized company based in France, with a long-standing expertise in
brazing dissimilar materials and specialized in the design and manufacture of complex
assemblies and sub-assemblies (RF and beamline components, components for X-ray
tubes, ceramic-metal assemblies…), as well as particle accelerators and disruptive medical
systems (a PET radiopharmaceutical system combining a cyclotron & radiochemistry and a
FLASH radiotherapy system)
Chelatec - Exhibition Partner
Chelatec was founded in 2000 by seasoned scientists trained in the development of radiopharmaceuticals. Experts in the use of radioactive tracers, they decided to offer their knowledge in preclinical development of targeted radiotherapeutics to pharma and biotech.
With state-of-the-art fully equipped laboratories for radiolabeling, radioanalyses, handling of cells and housing of animals, Chelatec is recognized for its reliable expertise and offers a unique combination of custom radiolabeling, in vitro assays and in vivo investigations capabilities.
Specializing in radiopharmaceutical R&D, Chelatec will provide you with information on your Investigational Medicinal Product to be part of the documentation package: all quality and nonclinical safety data required for translation of a radiopharmaceutical.
CheMatech - Exhibition Partner
CheMatech is a leading company specializing in the design and synthesis of bifunctional chelating agents such as DOTA, NOTA and NODAGA derivatives. These molecules are widely used for peptides or antibodies labelling especillay with 67/68Ga, 111In, 64/67Cu.
CheMatech offers a wide range of functionalized and protected chelating agents from milligrams to kilograms scale. CheMatech also offers custom syntheses, GMP production of chelators and bioconjugation services.
MIM Software - Exhibition Partner
MIM Software Inc. offers a comprehensive suite of applications that support Radiology and Nuclear Medicine’s important role in theranostics. MIM Software products emphasize the importance of quantitation, collaboration, and data management in order to provide physicians with the necessary information needed to generate confident clinical guidance and to inform effective treatments.
Trasis - Exhibition Partner
Trasis was founded in 2004 by Gauthier Philippart and Jean-Luc Morelle, the designers of the first radiosynthesizers to combine high-yield synthesis and GMP.
They put together their expertise and their knowledge of the radiopharmaceutical industry and founded Trasis, an innovative and forward-looking company. Trasis has now a track-record in developing instruments and methods recognized throughout the world.
At Trasis we are dedicated to helping the medical community access new radio-labelled therapeutic and
diagnostic substances easily and faster. To this end, we design, manufacture, sell and support high performance
synthesizers, dose preparation equipment, their shielding and accessories. We also develop customized synthetic methods and instruments. We can provide GMP Active Pharmaceutical Ingredients (API) and assist our customers with their regulatory affairs.
Our proven radiopharmaceutical expertise, coupled with our high end instruments allow us to provide fully
integrated solutions for an effective tracer production and faster transition from drug development to marketing authorization.
Our equipment is used worldwide in nuclear medicine departments, research centers, radiopharmaceutical
production facilities and pharmaceutical companies
SpextronRx - Exhibition Partner
SpectronRx provides therapeutic and diagnostic isotopes for clinical and research use - including theranostics, molecular radiotherapies and custom manufacturing. We are your curative supplier, specializing in providing you flexible and efficient contract manufacturing services. As a resource in the market, SPECTRONRx is an approved FDA manufacturer of radioactive drugs with many years of experience in custom manufacturing for major global research organizations and institutions.